Latest News
MS treatments on PBAC’s March 2020 agenda
It’s unusual to have three medications for treating MS before a meeting of the Pharmaceutical Benefits Advisory Committee (PBAC), for consideration for listing on the Pharmaceutical Benefits...
NDIS Tune Review sets the scene for (long overdue) change
MS Australia joins other disability peak organisations in welcoming the Tune Review...
Paralympian cyclist Emily Petricola talks to MS Australia about life with MS and training for Tokyo 2020.
Smart, funny and incredibly fit, Emily Petricola calls herself the “Queen of Denial”. “I prefer not to think about the things that are affecting my body”, says Emily.
Nevertheless, she is keen to work with MS Australia to broaden awareness of MS around the nation. Emily feels...
Are you in a current bushfire area?
If you are experiencing wheezing, chest tightness and difficulty breathing you should call triple zero (000) or TTY Emergency Service: Dial 106.
Please ensure you stay informed:
State specific information
ACT:
...
PBS listing for Siponimod (brand name Mayzent®) for SPMS not recommended by PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) announced today (20/12/19), that they have not recommended the listing of siponimod (Mayzent®) for secondary progressive MS (SPMS) on the Pharmaceutical Benefits Scheme (PBS), stating as follows:
“The PBAC did not recommend the listing...
Application to list Sativex on the PBS
MS Australia has been informed by Emerge Health that they have made an application to the March 2020 meeting of the Pharmaceutical Benefits Advisory Committee (PBAC) to have the medicinal cannabis product Sativex listed on the Pharmaceutical Benefits Scheme (PBS) for spasticity in MS. If...
MS Australia pays tribute to the life of Dr Leslie (Ladislav) Sedal, M.B, B.S., FRACP, M Ed. (04/09/1944 - 16/11/2019)
MS Australia’s top award presented to Professor Michael Pender
MS Australia is thrilled to announce that Professor Michael...
Australian Government approves amended PBS listing of two MS medications for children with RRMS, from 1 November 2019.
Today (Monday 28 October 2019) the Federal Health Minister, the Hon Greg Hunt MP announced the (amended) listing of two MS medications for children with relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS), from 1 November 2019.
The Federal Health Minister’s media...
National Carers Week 2019: Sunday 13 to Saturday 19 October
(Picture: Mo Hope; AFLW player, carer for her sister Vinny Hope, and spokesperson for this year's campaign.)
Unpaid carers make an...
Global MS patient-centred initiative launches
As the member organisation of the MS International Federation (MSIF) in Australia, MS Australia is delighted to share news of an important new global initiative.
Launching today (12/09/19) at the ...
PBAC recommends listing of two MS medications for children with relapsing remitting MS
On Friday 23 August, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of two MS medications for children with relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).
The two recommendations made by PBAC are as follows:
...